GLP-1RA Reward Behaviour Systematic Review (PubMed, 2024) GLP-1 Receptor Signalling in Reward Circuitry, Dopamine, and Addiction Research A systematic review of GLP-1 receptor agonist effects on reward behaviour published on PubMed following PRISMA guidelines across OVID, PubMed, Scopus, and Google Scholar evaluated the evidence for GLP-1Rs role in reward dysfunction across obesity, type 2 diabetes, and psychiatric conditions
100% carbon offset We recently revamped our packaging to reduce its carbon footprint by more than 1/3
Mochi Health is one of the 14 companies recently sued by Novo, and is also dealing with a lawsuit from Eli Lilly
Price per shot: $25 4-week treatment: $95 6-week treatment: $135 10-week treatment: $210 Lipo B & Lipo C These lipotropic injections help rid the body of fat while boosting energy
For tendon injuries, subcutaneous (SubQ) injection is the highly recommended method
While gastrointestinal side effects like nausea and vomiting were more common, there was no increased risk of hypoglycemia, suicide, or pancreatitis, underscoring the safety of GLP-1 RAs in this population